✦ LIBER ✦

Management of the adverse effects of lenalidomide in multiple myeloma

✍ Scribed by Ana Pilar González Rodríguez

Book ID: 107648726
Publisher: Springer Healthcare Communications
Year: 2011
Tongue: English
Weight: 545 KB
Volume: 28
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-010-0104-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple myeloma: management of adverse

Multiple myeloma: management of adverse events

✍ F. Gay; A. Palumbo 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 216 KB

Lenalidomide treatment for patients with

Lenalidomide treatment for patients with multiple myeloma: Diagnosis and management of most frequent adverse events

✍ Ernesto Pérez Persona; Mercedes Gironella Mesa; Pedro José García Sánchez; Ana P 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 467 KB

Lenalidomide in the treatment of multipl

Lenalidomide in the treatment of multiple myeloma: a review

✍ X. Armoiry; G. Aulagner; T. Facon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Efficacy of thalidomide- or lenalidomide

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma

✍ Kapoor, P; Kumar, S; Mandrekar, S J; Laumann, K M; Dispenzieri, A; Lacy, M Q; Di 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Inhibition of the mevalonate pathway pot

Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma

✍ Ellen van der Spek; Andries C. Bloem; Henk M. Lokhorst; Berris van Kessel; Lijni 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Management of renal dysfunction in multi

Management of renal dysfunction in multiple myeloma

✍ Sandeep R. Pandit; David H. Vesole 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 290 KB